ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Translational Session

The Yellow Brick Road? Rethinking Clinical Development Strategies in AKI

November 05, 2022 | 10:30 AM - 12:30 PM

Location: W320 Chapin, Orange County Convention Center, West Building

Session Description

This session explores the processes and opportunities to innovate in the development of new therapeutic agents for AKI. Particular emphasis is given to emerging concepts on clinical trial design, end point selection, and targeting the transition from AKI to CKD.

Learning Objective(s)

  • Identify how AKI models, model organisms, and experimental outcomes map to discrete AKI syndromes and trial populations
  • Describe how innovative end point selection in early-phase clinical trials could bolster the pipeline for AKI therapeutics
  • Discuss emerging trial design concepts and how they might be applied to AKI

Learning Pathway(s)

  • AKI and Critical Care
  • Pharmacology

Moderators

  • Javier A. Neyra, MD, MS, FASN
  • Danielle Soranno, MD

Presentations

  • What Makes for an Exciting Preclinical Data Packet for AKI or CKD?
    10:30 AM - 11:00 AM
    Katalin Susztak, MD, PhD
  • Rethinking End Points in Early Phase AKI Studies
    11:00 AM - 11:30 AM
    Sushrut S. Waikar, MD, MPH
  • An Adaptive Trial Platform for AKI? Promises and Perils
    11:30 AM - 12:00 PM
    Kathleen D. Liu, MD, PhD, FASN
  • Lessons for AKI Research from Pragmatic Trials
    12:00 PM - 12:30 PM
    Miguel A. Vazquez, MD, FASN